Ingevity (NYSE:NGVT) SVP Sells $199,707.48 in Stock

Ingevity Corporation (NYSE:NGVTGet Free Report) SVP Ryan Fisher sold 2,709 shares of Ingevity stock in a transaction dated Monday, August 3rd. The stock was sold at an average price of $73.72, for a total value of $199,707.48. Following the completion of the transaction, the senior vice president owned 15,722 shares in the company, valued at $1,159,025.84. The trade was a 14.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Ingevity Stock Performance

NYSE:NGVT traded up $2.06 during mid-day trading on Tuesday, hitting $75.47. 279,443 shares of the company’s stock traded hands, compared to its average volume of 295,636. The firm has a 50 day moving average of $71.90 and a two-hundred day moving average of $71.06. Ingevity Corporation has a 12 month low of $45.66 and a 12 month high of $79.29. The firm has a market capitalization of $2.59 billion, a price-to-earnings ratio of 51.34 and a beta of 1.16. The company has a current ratio of 1.61, a quick ratio of 1.15 and a debt-to-equity ratio of 22.52.

Ingevity (NYSE:NGVTGet Free Report) last issued its quarterly earnings results on Wednesday, July 29th. The company reported $1.74 EPS for the quarter, topping the consensus estimate of $1.33 by $0.41. Ingevity had a return on equity of 284.70% and a net margin of 4.65%.The company had revenue of $314.10 million for the quarter, compared to the consensus estimate of $312.20 million. Ingevity has set its FY 2026 guidance at 5.000-5.450 EPS. On average, equities analysts forecast that Ingevity Corporation will post 5.05 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several equities analysts recently commented on NGVT shares. Weiss Ratings upgraded shares of Ingevity from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Friday. Wall Street Zen lowered shares of Ingevity from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Two equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $80.00.

Check Out Our Latest Analysis on Ingevity

Institutional Trading of Ingevity

A number of hedge funds have recently modified their holdings of NGVT. Millennium Management LLC lifted its position in shares of Ingevity by 1.3% in the 3rd quarter. Millennium Management LLC now owns 1,189,524 shares of the company’s stock worth $65,650,000 after acquiring an additional 15,562 shares during the period. Royce & Associates LP increased its position in shares of Ingevity by 7.7% during the fourth quarter. Royce & Associates LP now owns 1,111,158 shares of the company’s stock valued at $65,758,000 after purchasing an additional 79,059 shares during the period. Brown Advisory Inc. raised its stake in shares of Ingevity by 15.4% in the fourth quarter. Brown Advisory Inc. now owns 1,040,944 shares of the company’s stock valued at $61,603,000 after purchasing an additional 138,859 shares in the last quarter. Simcoe Capital Management LLC raised its stake in shares of Ingevity by 9.4% in the fourth quarter. Simcoe Capital Management LLC now owns 1,020,945 shares of the company’s stock valued at $60,420,000 after purchasing an additional 87,490 shares in the last quarter. Finally, Victory Capital Management Inc. lifted its position in Ingevity by 7.4% in the fourth quarter. Victory Capital Management Inc. now owns 867,915 shares of the company’s stock worth $51,363,000 after purchasing an additional 60,163 shares during the period. Institutional investors own 91.59% of the company’s stock.

About Ingevity

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Articles

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.